|
| Status |
Public on Oct 18, 2016 |
| Title |
Transplant tissue specfic exosome platform for noninvasive monitoring of immunologic rejection [miRNA] |
| Platform organism |
synthetic construct |
| Sample organism |
Homo sapiens |
| Experiment type |
Non-coding RNA profiling by array
|
| Summary |
In transplantation, there is a critical need for non-invasive biomarker platforms for monitoring immunologic rejection. We hypothesized that transplanted tissues release donor specific exosomes into recipient circulation/ bodily fluids, and that the quantitation and profiling of their intra-exosomal cargoes would constitute a novel biomarker platform for monitoring rejection. We tested this hypothesis in a human into mouse xenogeneic islet transplant model, and validated the concept in clinical settings of islet and renal transplantation. In the xenogeneic model, islet transplant exosomes in recipient blood were quantified over long-term follow-up using anti-human leukocyte antigen (HLA) antibody that is only expressed on human islets (p=1.6x10-14). Transplant islet exosomes were purified using anti-HLA antibody conjugated beads and their cargoes contained bona fide islet endocrine hormone markers insulin, glucagon, and somatostatin. Rejection led to significant decrease in transplant islet exosome signal (p=4x10-15), along with distinct changes in its microRNA and proteomic profiles prior to appearance of hyperglycemia. In the clinical settings of islet (n=5) and renal (n=5) transplantation, donor exosomes with respective tissue specificity for islet β cells and renal epithelial cells were reliably characterized in recipient plasma over follow-up (up to 5 years; p=0.0001). Collectively, these findings demonstrate the biomarker potential of transplant exosome characterization for providing a non-invasive window into the conditional state of the transplant tissue.
|
| |
|
| Overall design |
We assessed an in vivo read-out of TISE cargo as compared to its transplanted human islet tissue counterpart. Transplant islet exosomes from two independent experiments were analyzed. Small RNA microarray profiling of islet exosomes and islet graft tissue was performed. Next, we attempted small RNA profiling of R (rejection)-xeno samples, but because of the low TISE levels from a single sample we had to pool transplant islet exosomes from 5 animals for microarray analysis.
|
| |
|
| Contributor(s) |
Vallabhajosyula P, Korutla L, Habertheuer A, Yu M, Rostami S, Yuan C, Reddy S, Liu C, Korutla V, Koeberlein B, Trofe-Clark J, Rickels MR, Naji A |
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| |
| Submission date |
Oct 17, 2016 |
| Last update date |
May 02, 2017 |
| Contact name |
Prashanth Vallabhajosyula |
| E-mail(s) |
Prashanth.Vallabhajosyula@uphs.upenn.edu
|
| Phone |
215 459 0487
|
| Organization name |
University of Pennsylvania
|
| Department |
Surgery
|
| Street address |
3400 Spruce Street
|
| City |
Philadelphia |
| State/province |
PA |
| ZIP/Postal code |
19104 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL19117 |
[miRNA-4] Affymetrix Multispecies miRNA-4 Array |
|
| Samples (3) |
|
| This SubSeries is part of SuperSeries: |
| GSE88846 |
Transplant tissue specfic exosome platform for noninvasive monitoring of immunologic rejection |
|
| Relations |
| BioProject |
PRJNA348762 |
